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Abstract A glucosyltransferase (GT) of Phytolacca
americana (PaGT3) was expressed in Escherichia coli
and puriﬁed for the synthesis of two O-b-glucoside
products of trans-resveratrol. The reaction was moder-
ately regioselective with a ratio of 40-O-b-glucoside:
3-O-b-glucoside at 10:3. We used not only the puriﬁed
enzyme but also the E. coli cells containing the PaGT3
gene for the synthesis of glycoconjugates. E. coli cell
cultures also have other advantages, such as a shorter
incubation time compared with cultured plant cells, no
need for the addition of exogenous glucosyl donor
compounds suchasUDP-glucose, and almostcomplete
conversion of the aglycone to the glucoside products.
Furthermore, a homology model of PaGT3 and muta-
genesis studies suggested that His-20 would be a
catalytically important residue.
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Introduction
Resveratrol, which is a naturally occurring hydroxy-
stilbene, has a broad range of biological activities and
can be used in treatments for the metabolic syndrome
(Cherniack 2011; Xianfeng-Huang and Zhu 2011). It
can lower the weight, blood pressure, glucose, and
insulinresistanceinrodents,andahumantrialwithitis
currently underway. However, the water-insolubility
of resveratrol limits its pharmacological exploitation
but its water-soluble derivatives, resveratrol 3-O-b-D-
glucoside and resveratrol 40-O-b-D-glucoside, show
pharmaceutical properties such as cancer prevention
(Ingram et al. 1998), anti-oxidant activity (Tikkanen
et al. 1998) and estrogenic activity (Gehm et al. 1997).
The glucosidation of trans-resveratrol is therefore of
considerable importance the further exploitation of
trans-resveratrol.
Cultured plant cells can be used to convert organic
moleculestomoreusefulcompounds(SugaandHirata
1990) by carrying out hydrolysis, oxidation, reduc-
tion, esteriﬁcation, isomerization, and glycosylation
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Glycosylation of bioactive compounds can enhance
water solubility, physicochemical stability, intestinal
absorption, and biological half-life (Vogt and Jones
2000). Many secondary metabolites accumulate in the
form of glycosides in plants suggesting that suspen-
sion of such cells would contain glucosyltransferases
(GTs), which catalyze the conjugation of an aglycone
and a glucosyl donor molecule (Furuya et al. 1989).
We previously reported that the plant cell cultures
from Phytolacca americana (Pa) glycosylated exog-
enous compounds (Noguchi et al. 2009). Three
glucosyltransferase cDNAs (PaGT1-3) were isolated
from P. americana. In this study, we report that
PaGT3, which accepts a broad range of substrates,
could catalyze regio- and stereo-speciﬁc glucosidation
of resveratrol using a puriﬁed enzyme as well as the
recombinant E. coli cells bearing the PaGT3 gene.
Furthermore, we constructed the PaGT3 model struc-
ture and performed mutagenesis studies in order to
examine amino acid residues involved in the substrate
recognition and the catalytic process.
Methods and materials
General
All chemicals were purchased from Wako, Nakalai,
and Sigma-Aldrich, and enzymes for mutagenesis
were obtained from Toyobo. HRFAB-MS spectra
were measured on a JEOL MS station JMS-700
spectrometer. The
1H-and
13C-NMR spectra were
recorded using Varian XL-400 spectrometer.
Glucosidation of trans-resveratrol with cultured
plant cells
Callus tissues from Phytolacca americana L. were
prepared(seeHamadaetal.2003).Callustissue(20 g)
was cultured under light for 4 weeks, transferred to
an Erlenmeyer ﬂask (300 ml) containing 100 ml
Murashige and Skoog (MS) liquid medium, and
cultured with continuous shaking at 25C. Ten mg of
trans-resveratrol was added to the ﬂask and the cells
were incubated for an additional 3 days at 25C.
Following incubation, the cells were isolated by
ﬁltration, and extracted with methanol (200 ml) for
24 h. The methanol fraction was concentrated and
partitioned between water (100 ml) and ethyl acetate
(300 ml); the ethyl acetate fraction was analyzed by
HPLC. The substrate and glucosylated products were
separated using YMC-Pack R&D ODS column and
acetonitrile/water (15:85, v/v) at 1 ml/min, with
detection at 280 nm. Product yields were calculated
based on the peak area from the HPLC proﬁle using
the calibration curves prepared by similar HPLC
analyses of known glycosides.
Glucosidation of trans-resveratrol by puriﬁed
PaGT3 enzyme
PaGT3 cDNA was cloned into pQE30 containing 6X-
His tag at the N-terminus, and the resulting pQE30-
PaGT3 plasmid was transformed into E. coli M15
cells. The transformants were cultured with continu-
ous shaking at 30C in the Luria- Bertani (LB) broth
containing 50 lg ampicillin/ml. After 16 h, 20 ml
culture was transferred to 2 l fresh LB broth, and
cultured with shaking at 30C; at OD600 = 1, IPTG
was added to 0.1 mM, followed by incubation at 30C
for an additional 16 h. To purify the PaGT3 enzyme,
theharvestedcellswerecollectedbycentrifugationfor
10 min 5,0009g resuspended in buffer H (15 mM
potassium phosphate, 1 mM EDTA, 2 mM 2-merca-
potoethanol). Cells were lysed by sonication, and
cellular debris were removed by centrifugation for
15 min 5,0009g, and the supernatant was applied to a
His-accept column equilibrated with buffer H. The
column was washed with buffer H to remove impu-
rities, and the bound PaGT3 enzyme was eluted with
buffer H supplemented with 200 mM imidazole. The
puriﬁed PaGT3 enzyme solution was dialyzed for
16 h at 4C with 50 mM potassium phosphate buffer
(pH 7.2).
The His-20 PaGT3 mutants were constructed from
pQE30-PaGT3 by polymerase chain reaction (PCR)
using primers 50-GCCCATGGGGCCATGATCCC
G-30 and 50- CGGGATCATGGCCCCATGGGC-30
for H20A PaGT3, and 50-GCCCATGGGGATATGA
TCCCG-30 and 50- CGGGATCATATCCCCATGG
GC-30 for H20D PaGT3. The plasmids with His-20
mutations were transformed into E. coli M15 cells and
characterized by sequencing.
Glucosidationreactionswereperformedat30Cfor
60 min in 0.5 ml 50 mM potassium phosphate buffer
(pH 7.2) supplemented with 50 lM trans-resveratrol,
100 lM UDP-glucose, and 1 lM PaGT3. The
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123substrates and glucosylated products were separated
using Insertsil ODS-3 column, and the standard
gradient program, which was as follows: the ratio of
water (A) to acetonitrile (B) was initially 80:20 at a
time 0–15 min, then the A:B ratio was linearly
increased from 80:20 (v/v) at t = 15 min to 20:80
(v/v) at t = 40 min followed by a ﬁnal wash with
100% acetonitrile. The UV–visible detector was set at
280 nm.
Glucosidation of trans-resveratrol by the E. coli
cell cultures
E. coli M15 cells containing pQE30-PaGT3 were
cultured as described above in 10 ml LB medium
containing 0.1 mg tans-resveratrol/l and 50 lg/ml
ampicillin. After induction for 16 h with 0.1 mM
IPTG, the cells and the medium were separated, and
the products were extracted from the medium with
2 9 10 ml ethyl acetate. Ethyl acetate was evaporated
using a rotary evaporatorand the residue was analyzed
by HPLC. Alternatively, the medium was applied to
Diaion HP-20 (1 g), washed with water, and eluted
with methanol. The methanol solution was analyzed
by HPLC using the standard gradient program.
Analysis
The
1H-and
13C-NMR spectra were recorded in
CD3OD. The chemical shifts were expressed in d
(ppm) referring to TMS.
1H-NMR spectra of trans-
resveratrol 3-O-b-glucoside and 40-O-b-glucoside were
essentially identical to those of authentic spectra (Weis
et al. 2006). The b-conﬁguration was conﬁrmed by
anomeric proton signals at d 4.80 (1H, d, J = 7.6 Hz)
and d 4.88 (1H, d, J = 7.6 Hz) for trans-resvera-
trol 3-O-b-glucoside and 40-O-b-glucoside, respec-
tively.
13C-NMR of trans-resveratrol 3-O-b-glucoside:
d139.3 (C-1), 107.1 (C-2), 158.0 (C-3), 102.7 (C-4),
158.8(C-5),104.7(C-6),125.1(C-7),128.5(C-8),129.9
(C-10), 128.0 (C-20), 115.5 (C-30), 157.2 (C-40), 115.5
(C-50), 127.8 (C-60), 100.6 (C-100), 73.3 (C-200), 76.7
(C-300), 69.8(C-400),77.1(C-500),60.8 (C-600).
13CN M R
of trans-resveratrol 40-O-b-glucoside: d138.3 (C-1),
104.4 (C-2), 158.4 (C-3), 102.0 (C-4), 158.2 (C-5),
104.4 (C-6), 127.1 (C-7), 127.5(C-8), 130.7 (C-10),
127.3 (C-20), 116.3 (C-30), 156.8 (C-40), 116.3 (C-50),
127.3 (C-60), 100.2 (C-100), 73.2 (C-200), 76.6 (C-300),
69.7 (C-400), 77.0 (C-500), 60.7 (C-600).
Construction of the homology modeling of PaGT3
The homology model of PaGT3 was constructed
using the Swiss-model (http://swissmodel.expasy.org)
with the crystal structure ofGTfromVitis vinifera (pdb
code: 2C1Z) as a template (Offen et al. 2006). The
modelandthetemplatewerecomparedusingtheSwiss-
pdb viewer(http://spdbv.vital-it.ch/)a n dP y M o l( http://
www.pymol.org/) (Kiefer et al. 2009; Kopp and Schw-
ede 2006;P e i t s c h1995).
Results and discussion
The production of trans-resveratrol 3-O-b-
glucoside and 40-O-b-glucoside by PaGT3
Cell suspension cultures of P. americana could glu-
cosylatetrans-resveratroltosynthesize3-O-b-glucoside
and 40-O-b-glucoside (Scheme 1). In this system, the
addition of UDP-glucose was not required because
glucosyl donor molecules were regenerated. Conjuga-
tion products were extracted from the cells and puriﬁed
by reverse phase HPLC (Fig. 1a). Under the reverse
phase HPLC conditions, 40-O-b-glucoside eluted faster
than3-O-b-glucoside,aspreviouslyreported(Weisetal.
2006). The HRFABMS spectra of these isolated gluco-
sides showeda pseudomolecularion[M ? H]
? peakat
m/z 391, suggesting a molecular formula of C20O8H22
(calculated for 390). The comparison of NMR spectra
with those of the known monoglucoside standards
conﬁrmed the synthesis of trans-resveratrol 3-O-b-
glucoside and 40-O-b-glucoside in the culture medium.
Interestingly, the product distribution was considerably
altered by the addition of 2,4-dichlorophenoxyacetic
acidasasyntheticauxintotheculturemedium(Fig. 1b).
The synthesis of 40-O-b-glucoside was notably
enhanced following incubation with the plant hormone.
To investigate the changes in regiospeciﬁcity, we
heterologouslyexpressed PaGT3inE. coli andpuriﬁed
the enzyme to synthesize the glucosides. When trans-
resveratrol was incubated with UDP-glucose in the
presence of PaGT3, 40-O-b-glucoside was obtained as
the major product (Fig. 1c). The ratio of peak area for
40-O-b-glucoside to that for 3-O-b-glucoside in the
HPLC proﬁle was 10:3. The product distribution was
not altered following the addition of 2,4-dichlorophe-
noxyacetic acid, phenyl acetic acid, or 1-naphthalene
acetic acid, indicating that these hormones do not
Biotechnol Lett (2012) 34:475–481 477
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these observations, we believe that 2,4-dichlorophe-
noxyaceticacidmayinducetheexpressionofPaGT3in
the cultured cells, resulting in enhanced 40-O-b-gluco-
side production. The expression and puriﬁcation of
PaGT1 and PaGT2 are now under way to examine the
regiospeciﬁcityfor the glucosidationreaction catalyzed
by these isozymes.
Biotransformation of trans-resveratrol
by E. coli cells
The results of this study show that puriﬁed PaGT3
catalyzes the glucosidation of trans-resveratrol. Next,
we attempted to use E. coli cells expressing PaGT3
gene to promote the glucoside synthesis because
E.colicellsgrowfasterthanP.americana cells.When
PaGT3-expressing E. coli cells were cultured in the
presence of trans-resveratrol, glucoside products of
trans-resveratrol were detected in the medium of
overnight culture. Interestingly, endogenous glucosyl
donor molecules were sufﬁcient for the reaction, since
thereactionoccurredevenwhenUDP-glucosewasnot
added to the medium. The products were extracted
from the medium using ethyl acetate and identiﬁed by
reverse-phase HPLC as 3-O-b–glucoside and 40-O-b–
glucoside. The glucosidation of trans-resveratrol was
almost 100% using this method, and a peak corre-
sponding to resveratrol, starting material, was not
observed in the HPLC proﬁle (Fig. 2). This was a
considerableimprovementbecauseonly39%oftrans-
resveratrol was glucosylated in P. americana cell
cultures. Furthermore, the use of E. coli cells allowed
the incubation time to be shortened from 3 days to 1.
The glucoside products accumulated in the medium
and could not be isolated from the cell extracts. Since
PaGT3 is not secreted from the E. coli cells, trans-
resveratrol and its glucoside products may pass
through the cell membrane. These results indicate
thatPaGT3expressingE.colicellsutilizeendogenous
UDP-glucose to convert trans-resveratrol completely
into the glucosides.
We also found that Diaion HP20 could be used to
isolate the glucoside products from the medium
instead of extracting the glucosides with ethyl acetate.
HO
OH
OH 4’
5
3
HO
OH
O
O
HO
OH
OH
CH2OH
1’’
O
OH
OH
O
HO
HO
HOH2C
OH
1’’
trans-resveratrol
3-O-
4’-O-
glucoside 
glucoside 
Scheme 1 Glucosidation of trans-resveratrol
Fig. 1 HPLC proﬁles of the glucosylated products obtained
from incubation with a Phytolacca americana cells in the
absence of auxin, b P. americana cells in the presence of 2,4-
dichlorophenoxyacetic acid, and c the puriﬁed PaGT3 enzyme.
* and ** indicate trans-resveratrol 40-O-b-glucoside and trans-
resveratrol 3-O-b-glucoside, respectively. d The starting mate-
rial trans-resveratrol was eluted at 31 min
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appeared to interact with the non-polar hydrophobic
surface of HP20 resin by van der Waals force, and the
glucoside products bound on the resin were eluted
with methanol. The use of HP20 is convenient for the
isolation of glucosylated products from the medium
obtained by a large scale incubation.
Molecular modeling and mutagenesis studies
The X-ray crystal structure of PaGT3 may yield
important insights into the reaction mechanism; how-
ever, the structure of PaGT3 has not yet been
determined. Therefore, we constructed a structural
model of PaGT3 using the crystal structure of GT
from V. vinifera (VvGT) as a template (Offen et al.
2006). The predicted PaGT3 structure was then
superimposed upon the crystal structure of VvGT
bearing UDP-2-deoxy-2-ﬂuoro glucose (a nontrans-
ferable donor molecule) and kaempferol (a glucose
acceptor molecule) at the active site for comparison
(Fig. 3a). A putative model structure of PaGT3
implies that Gln-395 may play an important role in
appropriate positioning of UDP-glucose, a glucose
donor molecule. trans-Resveratrol, a glucose acceptor
molecule, may bind PaGT3 in the hydrophobic pocket
surrounded by Phe-126, Leu-155, and Phe-392. A
histidine residue conserved in the active site of GTs
normallyacceptaprotonfromthehydroxygroupofan
acceptormoleculeandpromotethenucleophilicattack
on C1 of UDP-glucose (Fig. 3b) (Lairson and Withers
2004). The model structure of PaGT3 clearly suggests
that His-20 rather than His-18 is the catalytic residue.
Moreover, the hydrogen-bonding interaction between
the carboxy side chain of Asp-124 and the Nd atom of
His-20 might increase the basicity of this imidazole to
enhance the nucleophilicity.
30 25 20 15 10 5 0
Retention Time (min)
(a)
(b)
*
**
***
Fig. 2 HPLCproﬁlesofglucosylatedproductsobtainedfromthe
incubation of E. coli expressing a wild type PaGT3 gene and
bH20APaGT3gene.HPLCproﬁlebwassimilartothatobtained
intheincubationwithE.coliexpressingH20DPaGT3gene.*,**,
and *** indicate trans-resveratrol 40-O-b-glucoside, trans-resve-
ratrol 3-O-b-glucoside, and trans-resveratrol, respectively
(a) (b)
Fig. 3 aTheactivesiteofPaGT3model.ThepredictedPaGT3
structure was superimposed upon the crystal structure of VvGT
bearing UDP-2-deoxy-2-ﬂuoro glucose (nontransferable donor)
and kaempferol (acceptor). UDP-2-deoxy-2-ﬂuoro glucose (U),
kaempferol (K), and some selected active site residues of
PaGT3areshown.bSchematic diagramofactive siteofPaGT3
model. The dashed lines indicate hydrogen bonds. A hydrogen
bond between His-20 and the 40-hydroxy group of
trans-resveratrol may promote nucleophilic attack on C1 of
UDP-glucose to produce 40-b-O-glucoside
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important residue, we decided to substitute His-20
with Ala and Asp and measure the GT activityof these
mutants. The expression levels of the mutated
enzymes were comparable to the wild type enzyme.
We could successfully purify the mutant enzymes
using nickel-nitrilotriacetic acid afﬁnity columns and
analyzed their GT activity (Fig. 4). We were unable to
detect glucosidation products in the reaction mixture
containing trans-resveratrol (acceptor), UDP-glucose
(donor), and the H20A and H20D PaGT3 mutant
enzymes.TheincubationofE.colicellsexpressingthe
H20A and H20D mutant PaGT3 enzymes in the
medium containing trans-resveratrol did not produce
the glucosides either (Fig. 2). These results provided
theexperimentalevidencethatHis-20intheactivesite
was critical for the GT reaction. The mutagenesis of
residues interacting with an acceptor molecule might
allow us to construct a novel enzyme glucosylating a
broad range of biologically active molecules.
Conclusions
PuriﬁedPaGT3glucosylatestrans-resveratrolto40-O-
b-glucoside (a major product) and 3-O-b-glucoside
(a minor product). Based on homology modeling,
resveratrol may bind PaGT3 in a hydrophobic pocket
similar to the GT from V. vinifera (VvGT). The
predicted structure of PaGT3 indicated that His-20
probably was a catalytically important residue for
the nucleophilic attack of the aglycone on the C1 of
UDP-glucose. This was conﬁrmed by mutational
analysis because H20A and H20D PaGT3 mutant
enzymes lacked GT activity. Furthermore, E. coli
expressing the PaGT3 gene was used for the glyco-
conjugation of trans-resveratrol in the culture med-
ium. The advantages of using E. coli cell cultures are a
shorter incubation time compared with cultured plant
cells, no need for the addition of exogenous glucosyl
donor compounds, such as UDP-glucose, and the
almost complete conversion of the aglycone to the
glucoside products. The use of E. coli cell cultures
combined with molecular engineering of PaGT3 may
provide a new biocatalyst for the glucosidation of
aromatic compounds.
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